Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Tempus AI, Inc. - Class A Common Stock (NQ:TEM)

47.22 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 1, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Tempus AI, Inc. - Class A Common Stock

< Previous 1 2 3 4 5 6 Next >
Tempus AI Gears Up For Q4 Earnings After 101% YTD Surge
Tempus AI (TEM) reports Q4 earnings Monday, expected loss of 20 cents/share, $203.12M in revenues. Stock up 98.80% YTD. Analysts see 13.5% upside with consensus rating of Buy and $59.60 price target. 
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
Earnings Scheduled For February 24, 2025
Via Benzinga
8 Analysts Have This To Say About Tempus AI
Via Benzinga
Tempus AI: The AI Powerhouse That’s Revolutionizing Healthcare
Tempus AI, Inc.​​ is a cutting-edge health technology company that uses AI to improve patient care. 
Via Talk Markets
Topics Artificial Intelligence Stocks / Equities
Exposures Artificial Intelligence
Tempus to Present at TD Cowen's 45th Annual Health Care Conference
From Tempus AI, Inc.
Via Business Wire
Tempus AI Sees Surge In Institutional Holdings In Q4: Cathie Wood's Ark Invest, JPMorgan, And BlackRock Load Up On TEM Stock
Tempus AI has seen major funds like Ark, JPMorgan, UBS, Goldman, Barclays, and others investing in the company during the Q4 of 2024. 
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
Ares Management Upsizes Tempus Debt Facilities to $560 Million
From Ares Management Corporation
Via Business Wire
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Tempus to Participate in the Morgan Stanley Technology, Media and Telecom Conference
From Tempus AI, Inc.
Via Business Wire
25 Top AI Stocks That Could Boost Your Portfolio
Via The Motley Fool
Topics Artificial Intelligence
Exposures Artificial Intelligence
Conflicting Signals: Tempus AI's Stock Market Rally
Tempus AI's stock has soared on completed acquisitions and product launches, yet mixed analyst sentiment signals a need for careful investor review. 
Via MarketBeat
Topics Artificial Intelligence
Exposures Artificial Intelligence
Super Micro Computer, Intel, Alibaba And CVS Are Among Top 13 Large-Cap Gainers Last Week (Feb 10-Feb 14): Are The Others In Your Portfolio?
In the last week, these 13 large-cap stocks were top performers. Are they in your portfolio? HIMS, AUR, APP, SMCI, TEM, DKNG, INTC, MNDY, BROS, CVS, BABA, AAPL, ABNB. 
Via Benzinga
What's Going On With Tempus AI Shares Thursday?
Tempus AI, Inc. (NASDAQ:TEM) stock is trading higher on Thursday after the company announced a collaboration with the Institute for Follicular Lymphoma Innovation. 
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
Tempus Announces Collaboration with IFLI Aimed at Supporting Development of Targeted Therapies for Follicular Lymphoma
From Tempus AI, Inc.
Via Business Wire
Think It's Too Late to Buy Tempus AI Stock? Here's the Biggest Reason Why There's Still Time.
Via The Motley Fool
Topics Artificial Intelligence
Exposures Artificial Intelligence
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Tempus AI Stock Swings Wildly As Earnings Near, Retail’s Cautiously Optimistic After Insider Sales
The company has gained a lot of attention since launching an AI-enabled personal health app last month. 
Via Stocktwits
Topics Artificial Intelligence
Exposures Artificial Intelligence
Lattice Semiconductor, SelectQuote, Radiant Logistics And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
Artificial Intelligence (AI) Influence on Healthcare Market Expected to Generate Revenues of $610 Billion By 2034
EQNX::TICKER_START (OTCQB:AVAI),(NASDAQ:TEM),(NYSE:BBAI),(NASDAQ:TALK),(NASDAQ:SOUN) EQNX::TICKER_END 
Via FinancialNewsMedia
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
Tempus to Report Fourth Quarter and Full Year 2024 Financial Results on February 24
From Tempus AI, Inc.
Via Business Wire
Artificial Intelligence (AI) Influence on Healthcare Market Expected to Generate Revenues of $610 Billion By 2034
From FN Media Group LLC
Via GlobeNewswire
Tempus AI Executives Sell $20 Million In Stock As Cathie Wood Buys And Nancy Pelosi Eyes Options
Multiple executives at Tempus AI Inc. executed significant share sales totaling $20.3 million between Feb. 4-7, according to recent Securities and Exchange Commission filings. The transactions occurred... 
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
Palantir, Super Micro Computer And Spotify Are Among Top 10 Large Cap Gainers Last Week (Feb 3-Feb 7): Are The Others In Your Portfolio?
Top performing large-cap stocks last week with strong financial results and raised price forecasts. Are they in your portfolio? 
Via Benzinga
Expedia Posts Strong Results, Joins Affirm Holdings, Take-Two, Cloudflare And Other Big Stocks Moving Higher On Friday
Via Benzinga
Electronic Arts Posts Upbeat Earnings, Joins Mattel, Johnson Controls, Mueller Water Products And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
Jim Cramer: This Health Care Stock Is A 'Winner,' Buy Bitcoin Instead Of Coinbase
On CNBC's “Mad Money Lightning Round,” Jim Cramer recommended buying AbbVie Inc. (NYSE:ABBV), saying it's “just a gem” and a “winner.”  He added, “I can't believe the stock dropped so much.” 
Via Benzinga
Why Palantir Shares Are Trading Higher By Over 16%; Here Are 20 Stocks Moving Premarket
Via Benzinga
AI Stocks Are Rallying After The Bell: What's Going On?
Several AI-linked stocks are trading higher in Monday's after-hours session after Palantir Technologies shares rocketed higher on the back of blowout earnings. Here's what you need to know. 
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
Tempus Completes Acquisition of Ambry Genetics
From Tempus AI, Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.